Glycomine Inc.

Glycomine Inc.

Biotechnology Research San Carlos, California, United States 23 employees FOR
Employees
23
Contacts
2
Emails
2
Phones
2

Glycomine Inc. Overview

Headquarters
San Carlos, California, United States
Phone Number
Available in AeroLeads
Website
glycomine.com
Industry
Biotechnology Research
Employees
23
Stock Symbol
FOR
Funding
115.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Glycomine Inc.

Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist. The company's approach is to use replacement therapies – substrates, enzymes, or proteins – and to target those molecules to clinically relevant cellular compartments. Glycomine’s lead drug candidate, GLM101, is a novel substrate replacement therapy in development to treat phosphomannomutase 2-congenital disorder of glycosylation (PMM2-CDG), a rare disease representing a critical unmet medical need.

Glycomine Inc. Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage
Phone contacts
2
50.0% coverage

Glycomine Inc. Org Chart

Sample employees and titles
Name Title Contact
Colette Muenzen Senior Legal Consultant
View
Kevin Herlihy Senior Director, Manufacturing Science and Technology
View
Steven Axon
Email Phone
Geoffrey Hird CTO at Glycomine Inc.
Email Phone

Employees by Management Level

Director 2 profiles
Senior / Lead 2 profiles
Individual contributor 2 profiles
Executive 1 profile
Intern / trainee 1 profile

Department Contact Coverage

Department Contacts Email Phone
Healthcare 1 1 1
Executive 1 1 1
General 1 1 0

Glycomine Inc. Tech Stack

Data / AI 1 profile

Compare Similar Companies to Glycomine Inc.